Life Science Analytics (LSA)

Life Science Analytics, Inc. (LSA) is devoted to providing exhaustive financial, venture and pipeline information on over 16,000 global biomedical companies.

LSA’s valuable data and research products are in great demand among pharmaceutical, biotechnology, and financial industry executives. The company’s products, including MedTRACK and MedTRACK Venture Finance, provide an unprejudiced, careful, independent approach to company assessment, whether for investment or partnering purposes.


Research Reports By Life Science Analytics (LSA)

Found 400 publications
Vitamin Deficiency Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 282 pages
Panic Disorder Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 87 pages
Depression Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 941 pages
Motion Sickness Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 61 pages
Hypertension Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 2288 pages
Type I Diabetes Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 230 pages
Ovarian Cancer Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 589 pages
Malaria Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 379 pages
Hyper pigmentation Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 55 pages
Thrombosis Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 435 pages
Ocular Inflammation Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 173 pages
Constipation Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 413 pages
Liver Cancer Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 419 pages
Neutropenia Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 67 pages
Cervical Cancer Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 120 pages
Hemorrhage Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 229 pages
Flatulence Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 68 pages
Epilepsy Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 663 pages
Myocardial Infarction Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 266 pages
Breast Cancer Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 1178 pages
Rosacea Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 71 pages
Dysmenorrhea Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 74 pages
Multiple Myeloma Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 672 pages
Hypotension Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 81 pages
Diarrhea Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 401 pages
Rabies Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 64 pages
Diabetic Macular Edema Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 129 pages
Protozoal Infection Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 52 pages
Pertussis Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 79 pages
Atherosclerosis Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 184 pages
Angina Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 457 pages
Allergy Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 1315 pages
Wrinkles Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 198 pages
Actinic Keratosis Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 152 pages
Vertigo Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 63 pages
Pancreatic Cancer Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 403 pages
Dental Pain Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 61 pages
Migraine Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 421 pages
Hyperphosphatemia Therapy Area Pipeline Report US$ 1,495.00 Sep, 2010 105 pages
1 2 3 4 5 ... 8
Skip to top